Shandong New-Line Bio and South Korea's CTC Bio sign a comprehensive strategic cooperation agreement to expand bacteriophage bio-products globally.

Shandong New-Line Biotechnology official announcement regarding: Festive Greetings! Shandong New-Line Bio Celebrates National Holiday and Grand Opening.

Shandong New-Line Biotechnology and UCAS Ningbo Institute partner to establish a joint bacteriophage research laboratory tackling multidrug-resistant bacteria in intensive farming.

On October 26, 2023, Shandong New-Line Biotechnology Co., Ltd. ("New-Line") announced further good news: the unveiling ceremony of the "Phage Industry Research Institute" was a complete success, signaling fresh momentum for New-Line's development and an unstoppable growth trajectory.

FDA approvals and clinical expansions of bacteriophage therapeutics signal a transformative global paradigm shift toward biological alternatives to conventional chemical antibiotics.

Executive leaders from CP Chia Tai Group visited Shandong New-Line Biotechnology Co., Ltd. for in-depth exchanges on phage technology applications in industrial farming and green feeding systems.

Municipal leaders visited New-Line Bio to review manufacturing expansion progress and discuss strategic support for bio-industrial parks.

Distinguished scientist Prof. Wang Ran and Weicheng district officials toured New-Line Bio's laboratories, holding in-depth discussions on phage R&D.

An introduction to Shandong New-Line Bio's core corporate values, modern production standards, and relentless pursuit of excellence in phage bio-products.

A specialized feature interview introducing the scientific journey, core patents, and industrial vision of New-Line Bio's founding team.

Detailing New-Line Bio's rigorous quality assurance system, cGMP manufacturing standards, and standardized phage titer testing methodologies.

Exploring New-Line Bio's proprietary phage library and high-throughput screening platform empowering China's agricultural green transition.